- Home
- BBU vs WGS Comparison
BBU vs WGS Comparison
Compare BBU & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBU
- WGS
- Stock Information
- Founded
- BBU 2016
- WGS 2017
- Country
- BBU Bermuda
- WGS United States
- Employees
- BBU N/A
- WGS N/A
- Industry
- BBU Engineering & Construction
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- BBU Consumer Discretionary
- WGS Technology
- Exchange
- BBU Nasdaq
- WGS Nasdaq
- Market Cap
- BBU 2.4B
- WGS 2.4B
- IPO Year
- BBU N/A
- WGS N/A
- Fundamental
- Price
- BBU $34.25
- WGS $138.87
- Analyst Decision
- BBU Buy
- WGS Strong Buy
- Analyst Count
- BBU 6
- WGS 8
- Target Price
- BBU $34.67
- WGS $130.63
- AVG Volume (30 Days)
- BBU 81.7K
- WGS 568.9K
- Earning Date
- BBU 11-06-2025
- WGS 10-28-2025
- Dividend Yield
- BBU 0.73%
- WGS N/A
- EPS Growth
- BBU N/A
- WGS N/A
- EPS
- BBU N/A
- WGS 0.07
- Revenue
- BBU $30,103,000,000.00
- WGS $402,190,000.00
- Revenue This Year
- BBU N/A
- WGS $39.54
- Revenue Next Year
- BBU $5.85
- WGS $22.50
- P/E Ratio
- BBU N/A
- WGS $1,896.75
- Revenue Growth
- BBU N/A
- WGS 50.50
- 52 Week Low
- BBU $18.63
- WGS $55.17
- 52 Week High
- BBU $36.72
- WGS $146.00
- Technical
- Relative Strength Index (RSI)
- BBU 53.15
- WGS 64.95
- Support Level
- BBU $34.12
- WGS $128.75
- Resistance Level
- BBU $35.50
- WGS $142.27
- Average True Range (ATR)
- BBU 1.10
- WGS 9.15
- MACD
- BBU -0.31
- WGS 1.50
- Stochastic Oscillator
- BBU 29.41
- WGS 79.89
About BBU Brookfield Business Partners L.P. Limited Partnership Units
Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.